This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland

Mark Hogarth, PhD
Professor and Burnet Senior Principal Research Fellow at Burnet Institute
Speaker

Profile

Mark Hogarth is a Senior Principal Research Fellow of the Burnet Institute and holds Professorships at the University of Melbourne and Monash University.

Prof Hogarth’s research teams have made major contributions over 30 years to discovery of the mechanisms of antibody effector function in normal and pathological immunity which also underpin the understanding of the action of monoclonal antibody drugs. The research has led to the generation of candidate biological and chemical therapeutics.

He has advised start-up and major companies on the development of their biological therapeutics and has extensive experience in the translation and commercialisation of biomedical research.

Prof Hogarth distinctions include the Gottschalk Medal (Australian Academy of Science) and the Sir Albert Coates Oration (Albert Coates Foundation).

www.burnet.edu.au/staff_members/182_mark_hogarth

Agenda Sessions

  • Stellabody® Transforms Killing and Agonism Potency of Antibody and Ig-like Biologics

    11:00